# Lento Bio, Inc — Form D

Lento Bio, Inc of LAFAYETTE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-31. The offering totals $5.0M. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-05-31
- Form: D
- Accession: 0001979322-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $10K
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-482922

## Issuer

- Name: Lento Bio, Inc
- CIK: 0001979322
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2561 US 11, LAFAYETTE, NY, 13084
- Phone: 6466760476

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Kris Barnes | Director | Warners, NY |
| Kelsey Moody | Director | Syracuse, NY |
| Kenneth Scott | Director | Dunedin, FL |
| Kris Barnes | Executive Officer | Warners, NY |

## More

- [CIK 1979322 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1979322&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001979322-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.